Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
-
Moesin and Endothelial Injury in Sepsis
2026-08-22
The reference study identifies circulating moesin (MSN) as a biomarker associated with endothelial injury and sepsis severity, while also connecting MSN activity to Rock1/MLC and NF-κB signaling. Its combined patient, animal, and endothelial-cell design provides a practical framework for linking biomarker measurements with vascular permeability mechanisms.
-
Reading Plastic Toxicity Through Better Immunodetection
2026-08-22
Mechanistic toxicology is only as persuasive as its measurement strategy. This article examines how immunodetection design can strengthen studies of microplastic- and nanoplastic-associated pulmonary fibrosis, while showing where the HRP Rabbit Anti-Goat IgG (H+L) Antibody fits into reproducible translational workflows.
-
Azithromycin: Stability-Aware Research Design
2026-08-21
Azithromycin is a macrolide antibiotic whose analytical stability can directly influence bacterial infection research. This guide connects ribosomal mechanism, TLC impurity profiling, resistance assays, and cross-domain model selection into a reproducible workflow.
-
Ciprofloxacin Hydrochloride: Applied Workflows
2026-08-20
Ciprofloxacin hydrochloride is a practical benchmark for bacterial DNA replication inhibition and a useful comparator in host–pathogen screening. This guide translates its fluoroquinolone mechanism, formulation constraints, and emerging immunomodulatory context into reproducible assay workflows and troubleshooting decisions.
-
Enzalutamide, ARv7, and TNBC Metastasis
2026-08-20
This 2025 study links androgen receptor variant 7 (ARv7) expression with adverse survival and distant metastasis in triple-negative breast cancer (TNBC), then tests AR-directed inhibition in MDA-MB-231 cells. Its main contribution is the integration of patient pathology, TCGA-BRCA analysis, and mechanistic assays to connect AR/ARv7 targeting with EMT and metastasis-related signaling.
-
TCAIM Control of OGDH and Mitochondrial Metabolism
2026-08-19
The 2025 Molecular Cell study identifies TCAIM as a mitochondrial DNAJC co-chaperone that specifically binds native OGDH and promotes its reduction through HSPA9 and LONP1. This finding expands the role of mitochondrial proteostasis from protein folding toward selective control of metabolic enzyme abundance and carbohydrate catabolism.
-
Azilsartan Medoxomil Monopotassium in Research
2026-08-19
Build more reproducible hypertension, cardiovascular, and renal experiments with Azilsartan medoxomil monopotassium (TAK 491), from solvent handling through receptor and blood-pressure readouts. The workflow connects sustained AT1-receptor antagonism with evidence from randomized trials, helping researchers choose concentrations, endpoints, and troubleshooting controls with greater confidence.
-
Human iPSC Sensory Neurons for HSV-1 Latency
2026-08-18
Oh and colleagues developed a scalable human sensory-neuron model from hiPSCs and validated its ability to support HSV-1 latency and reactivation. The system combines neuronal functional validation with virologic, transcriptional, and chromatin-based criteria, providing a more human-relevant platform for studying neuron-intrinsic mechanisms of persistent infection.
-
Flubendazole Workflows for Autophagy Research
2026-08-18
Flubendazole provides a DMSO-compatible pharmacological handle for testing how autophagy modulation intersects with macrophage-derived EV signaling in breast cancer models. This workflow pairs flux-aware autophagy assays with the miR-660–KLHL21–IKKβ/NF-κB axis to separate pathway effects from nonspecific toxicity or migration changes.
-
HRP Goat Anti-Rabbit IgG (H+L) Antibody
2026-08-17
This HRP-conjugated secondary antibody supports enzyme-based detection of rabbit IgG in Western blotting, ELISA, IHC, and IC workflows. It should be validated in the intended sample matrix and is not a diagnostic reagent or a substitute for a subclass-specific or directly labeled primary antibody.
-
TBK1, Microglia Pyroptosis, and Painful Diabetic Neuropathy
2026-08-17
Liao et al. identify TANK-binding kinase 1 (TBK1) as a mechanistic link between spinal microglial pyroptosis and painful diabetic neuropathy. Using type 1 and type 2 diabetic mouse models, genetic silencing, pharmacological inhibition, behavioral testing, and tissue analyses, the study shows that TBK1 inhibition can reduce hyperalgesia and peripheral nerve injury.
-
Guanabenz Acetate for GPCR Assays
2026-08-16
Guanabenz Acetate provides subtype-aware α2-adrenergic receptor control for GPCR, neuroscience, and stress-response experiments. This guide translates its DMSO handling profile into practical workflows and shows how receptor perturbation can be paired—without overclaiming—with GADD34, stress-granule, and IRF3 readouts.
-
DiR for Long-Term Membrane and EV Tracking
2026-08-15
DiR (DiIC 18 (7)) combines durable membrane retention with near-infrared imaging for live-cell, tissue, neuronal, and extracellular-vesicle workflows. This practical guide connects labeling chemistry to EV biodistribution studies, with starting parameters, controls, and troubleshooting strategies for cleaner quantitative imaging.
-
EZ Cap™ Human PTEN mRNA in Cell Assays
2026-08-14
This scenario-driven guide shows how EZ Cap™ Human PTEN mRNA (SKU R1025) can help researchers separate PTEN biology from delivery and assay variability in viability, proliferation, and cytotoxicity experiments. It connects product specifications with practical controls, handling parameters, interpretation strategies, and recent PTEN mRNA delivery research.
-
Necrostatin 2 (Nec-2) in Cell Death Assays
2026-08-14
Use Necrostatin 2 (Nec-2) to interrogate apoptosis-resistant cell death, validate RIPK2-linked signaling, and distinguish necroptosis from ferroptotic membrane failure. This practical guide combines concentration planning, orthogonal readouts, and insights from a recent TMEM16F study without assuming that Nec-2 directly inhibits ferroptosis.